College Student Allegedly Drugged and RAPED in Dorm

Gothic-style university building with central stone tower — Photo: Mihail Degteariov / Shutterstock

Federal prosecutors in Manhattan have laid out, in charging-document detail, exactly how two young men allegedly turned a counterfeit drug sale into a case that ended with one college student dead and another nearly so — a sequence that illustrates, with grim precision, why the fentanyl crisis is no longer confined to the stereotype of the chronic user.

Key Points

A federal grand jury returned a three-count superseding indictment against Moises Freire and Brian Peralta Cabrera, alleging a fentanyl-distribution conspiracy that killed one Fashion Institute of Technology student and nearly killed another.
Prosecutors allege Freire brought fentanyl misrepresented as cocaine into a Manhattan dorm on March 18, encouraged two students to use it, and did not use it himself.
The indictment includes a charge of distributing a controlled substance with intent to commit rape, alleging Freire assaulted one victim after she lost consciousness.
The deceased student has been identified in media reports as Annabel Richter, 21; both defendants have pleaded not guilty to earlier charges and had not yet been arraigned on the new indictment.
The case sits inside a national pattern: fentanyl was involved in 75% of overdose deaths among 10- to 19-year-olds from 2020 through 2024, frequently because the user did not know the drug was in what they took.

What the Indictment Alleges

The U.S. Attorney’s Office for the Southern District of New York announced on October 15, 2026, that a federal grand jury had indicted Freire and Peralta Cabrera on a three-count superseding indictment tied to a fentanyl-distribution conspiracy inside a Manhattan college residence hall. The government’s theory is specific rather than speculative: on March 18, Freire allegedly brought fentanyl he obtained from Peralta Cabrera to two Fashion Institute of Technology students in Nagler Hall, presenting it to them as cocaine. Both students, according to the indictment, lost consciousness almost immediately after ingesting it. Freire, notably, did not use the substance himself — a detail prosecutors are expected to use to argue he knew precisely what he was handing over.

That knowledge element matters enormously in a federal “distribution resulting in death” prosecution, and it’s where the indictment’s language becomes most damning: prosecutors allege Freire had previously described the substance as “fake” and “poison” before encouraging its use. The indictment also charges Freire with distributing a controlled substance with intent to commit rape, alleging he sexually assaulted one of the unconscious victims and waited roughly 45 minutes before alerting campus security. The surviving student was hospitalized and recovered. The other, identified in press accounts as Annabel Richter, never regained consciousness; she died of complications from acute fentanyl intoxication.

Why Federal Prosecutors Reach for the “Resulting in Death” Statute

Cases like this one are charged federally, rather than left to state courts, because Congress built a specific tool for exactly this scenario: 21 U.S.C. § 841, which imposes a mandatory minimum sentence — often twenty years to life — when death or serious bodily injury “results from” the distributed substance. Circuit courts have repeatedly upheld convictions where a defendant sold a drug knowing, or recklessly disregarding, that it contained fentanyl, even when the buyer believed they were purchasing something else entirely. That line of precedent — from distributors convicted after supplying fentanyl disguised as heroin, Percocet, or cocaine to unsuspecting buyers — is precisely the legal architecture the Southern District appears to be building on here: a defendant who allegedly knew the substance was dangerous, misrepresented it anyway, and distributed it to people who had no reason to expect fentanyl.

The causation requirement is the government’s heaviest lift. Courts have held that prosecutors must show the drug was a but-for cause of death, not merely a contributing factor — a standard the Supreme Court has scrutinized closely in prior fentanyl cases where multiple substances were involved. That’s a technical hurdle future proceedings in this case will need to clear, but it does not change what has already been alleged and charged; it simply describes the proof prosecutors will have to present at trial.

The Fentanyl Supply Problem Behind the Headline

This case did not emerge from a vacuum. It sits atop a well-documented public health crisis in which fentanyl — a synthetic opioid roughly fifty times more potent than heroin — has infiltrated the recreational drug supply so thoroughly that buyers routinely cannot identify what they’re actually taking. The CDC reports that fentanyl was involved in 75% of overdose deaths among Americans aged 10 to 19 between 2020 and 2024, overwhelmingly because counterfeit pills or adulterated substances contained fentanyl the user never knew about. The Drug Enforcement Administration seized more than 60 million fentanyl-laced counterfeit pills nationwide in 2024 alone, a figure that reflects enforcement activity rather than the true scale of what’s circulating, but still signals how saturated the illicit supply has become. College dorms, long treated as relatively insulated from street-level drug risk, are no longer exempt from that reality.

The Defense and the Procedural Record

Both men have pleaded not guilty to the original charges filed after their arrests in March, and neither had been arraigned on the new superseding indictment as of its announcement. At an earlier hearing, Freire’s attorney, Mitchell Schwartz, called Richter’s death a tragedy but disputed the government’s framing, describing what preceded the overdoses as “a story of teenagers doing what I would call ‘dumb teenager things'” rather than a deliberate scheme to ply students with drugs. That is the defense’s on-record position; it does not alter the specific, charged allegations now before the court, but it is part of the case record and belongs in any honest account of where things stand.

Institutional Response and What Comes Next

The Fashion Institute of Technology has since required its public-safety supervisors to carry naloxone, the opioid-overdose reversal medication, a policy change implemented directly in response to Richter’s death. An email attributed to the school acknowledged “we lost a beloved member of the FIT community earlier this year” without detailing the underlying facts of the case. For the defendants, the path forward runs through arraignment on the superseding charges, pretrial motions likely contesting both the causation theory and the sexual-assault count, and eventually a trial where the government will need to convert indictment allegations into evidence a jury accepts beyond a reasonable doubt. For everyone else, the case is a stark reminder that fentanyl’s danger no longer requires seeking out opioids at all — it can arrive disguised as something else entirely, in places people have every reason to consider safe.